Skip to main content
. 2019 Jul 5;7:161. doi: 10.3389/fbioe.2019.00161

Figure 10.

Figure 10

The mechanisms proposed for the action of strontium ranelate (SrR) on the bone cells. SrR can stimulate bone formation through activating some well-known receptors such as the calcium-sensing receptor (CaSR) and increasing prostaglandin E2 (PE2) production by osteoblasts. In contrast, SrR can inhibit bone resorption via increasing osteoprotegerin and decreasing receptor activator of nuclear factor kappa B ligand (RANK) expression by osteoblasts. Adapted from Marie (2007) with permission.